U.S. flag

An official website of the United States government

NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe) AND Nonsyndromic genetic hearing loss

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 28, 2021
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002228014.1

Allele description [Variation Report for NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)]

NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)

Gene:
MYO15A:myosin XVA [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p11.2
Genomic location:
Preferred name:
NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)
Other names:
I892F; NM_016239.4(MYO15A):c.6337A>T
HGVS:
  • NC_000017.11:g.18145935A>T
  • NG_011634.2:g.42230A>T
  • NM_016239.4:c.6337A>TMANE SELECT
  • NP_057323.3:p.Ile2113Phe
  • NC_000017.10:g.18049249A>T
  • NC_000017.10:g.18049249A>T
  • NG_011634.1:g.42230A>T
  • Q9UKN7:p.Ile2113Phe
Protein change:
I2113F; ILE892PHE
Links:
UniProtKB: Q9UKN7#VAR_010304; OMIM: 602666.0001; dbSNP: rs121908965
NCBI 1000 Genomes Browser:
rs121908965
Molecular consequence:
  • NM_016239.4:c.6337A>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Nonsyndromic genetic hearing loss
Synonyms:
Nonsyndromic hearing loss and deafness; Non-syndromic genetic deafness; Nonsyndromic genetic deafness
Identifiers:
MONDO: MONDO:0019497; MedGen: C5680182; Orphanet: 87884

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002512128ClinGen Hearing Loss Variant Curation Expert Panel
reviewed by expert panel

(clingen hl acmg specifications otof myo15a v1)		Likely pathogenic
(Sep 28, 2021) 		germlinecuration

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Hearing Loss Variant Curation Expert Panel, SCV002512128.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The p.Ile2113Phe variant in the MYO15A gene was absent from gnomAD v2.1.1 (PM2_Supporting). However, it has been described as a founder variant with a carrier frequency of 25/100 in Bengkala, Bali (PMID: 9603736). It has been identified in the homozygous state in 1 Bengkala kindred with hearing loss and in the heterozygous state in one Chinese individual with hearing loss (PMIDs: 9603736, 27018975). The p.Ile2113Phe variant has been reported to segregate with hearing loss in at least 6 family members (PP1_Strong; PMID: 9603736). The REVEL computational prediction analysis tool produced a score of 0.91, which is above the threshold necessary to apply PP3 (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for autosomal recessive hearing loss based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel (PP1_Strong, PM2_Supporting, PP3).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024